Schedule 13D ownership disclosure
TENAX THERAPEUTICS INC
Security class unavailable · CUSIP: 88032L209
Event date: 2020-05-18
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 470,000
- Percent of class
- 5.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001783976-20-000008
- Form type
- SC 13D
- Filer
- Binsalamah Ziyad
- CIK
- CIK 1783976
- Filed
- May 18, 2020
- Reporting period
- May 18, 2020
- Description
- Schedule 13D beneficial ownership